Exhibit Hall Highlights
Visit the DIA 2022 Exhibit Hall: A Can’t-Miss Experience
The DIA Global Annual Meeting offers a unique engagement experience that is designed to foster interactions that connect you to new opportunities, the latest innovations, and life-long relationships.
Stay up to date with the latest innovations from exhibitors across the global health care spectrum. Interact with forward-thinking professionals and industry experts and get a glimpse into the future of your field.Booth Giveaway Listing
Visit the DIA 2022 Exhibit Hall for:
- Updates on the Latest Innovations
- DIA Community Round Table Discussions
- Innovation Theater Presentations
- Network during Lunch and Refreshment Breaks
- Share Industry Perspectives
- Exhibitor Giveaways and Prizes
- Food Court for Convenience
Stay Tuned for More Information on the DIA Global App!
Exhibit Hall Hours:
- Monday, June 20 | 11:00am – 6:00pm (Reception 5:00 – 6:00pm)
- Tuesday, June 21 | 10:00am – 5:00pm
- Wednesday, June 22 | 10:00am – 4:30pm
Innovation Theater Presentations:
- Monday - Wednesday | 10:20am – 5:45pm
Interact at our DIA Booth!
Network with Expert Speakers and our Program Committee
Gain DIA Membership Benefits and Updates
Explore Stakeholder Perspectives
Meet DIA’s Science Team at Our Booth
The Future of Healthcare
Monday, June 20
9:45 - 10:00 AM
11:30 AM - 12:15 PM
12:45 - 1:15 PM
3:45 - 4:00 PM
Innovation Through Collaboration
Tuesday, June 21
10:15 - 11:00 AM
12:15 - 12:30 PM
1:30 - 1:45 PM
4:00 - 4:15 PM
Wednesday, June 22
10:15 - 11:00 AM
12:15 - 12:45 PM
1:30 - 1:45 PM
4:00 - 4:15 PM
Courtney Granville, PhD, MSPH, Global Associate Director, Research & Scientific Programs Drug Information Association
Dr. Granville brings over 2 decades of biomedical and regulatory science-related research experience to her role at DIA. As Global Associate Director of Research & Scientific Programs, Dr. Granville provides insights, guidance, and a collaborative approach to build DIA’s research and thought leadership in support of organizations working to bring innovation and efficiency to biomedical product development.
Dr. Granville’s research career focused on developing data to support regulatory decision-making in the fields of tobacco regulatory science, preclinical and molecular toxicology, nonclinical drug development, and public health. She has worked in academic, government, and industry laboratories leading both clinical and non-clinical research studies, assuring IRB and GLP compliance where relevant. Dr. Granville was the Principal Investigator for studies to define the toxicity of new and modified tobacco products in an FDA-funded Tobacco Center of Regulatory Science (TCORS). She also has experience leading more than 20 GLP nonclinical rodent studies as study director, developing data on the toxicity of high-volume chemicals, natural products used as dietary supplements, and viral vectors. In each of these roles, Dr. Granville’s primary responsibilities were to lead protocol development and compliance, assure documentation of all study-related activities, and analyze and report findings.
Tamei Elliott, MS, Senior Manager, Scientific Programs, Drug Information Association
The Future of Healthcare is Global
Tamei Elliott is the Senior Manager of Scientific Programs for the Americas Region at DIA. She is responsible for identifying and prioritizing content areas and topics of importance to DIA constituents, assessing the implications of important regulatory and health policy changes, and incorporating appropriate content into the development and advancement of content for DIA Americas conferences and courses. She engages with external thought leaders, internal experts, volunteers, DIA Learning staff, and paid content generators to identify and deliver content for DIA conferences, courses, communities, and other products.
Prior to DIA, Tamei worked as a Regulatory Affairs Specialist where she maintained a portfolio of INDs and protocols for clients and was responsible for the preparation, tracking, and submission of regulatory documents to regulatory health authorities. Tamei received her Bachelor of Science in Nutritional Science from Howard University and Master of Science in Biotechnology from Johns Hopkins.
Maria Paula Bautista Acelas, MSHCM, Research Associate, Scientific Programs, Drug Information Association
Maria Paula is the Research Associate of the Scientific Programs team at DIA. Currently, she is supporting ongoing research related to Patient Engagement in collaboration with Tufts University CSDD and provides support to grow the Research Portfolio, in addition, she is the leader of the DIA Patient Engagement Thought Stream.
She has previous experience working in Patient Engagement research focused on understanding the health care beliefs among cultural-diverse patients through empathetic communication aimed to improve the quality of care for underserved populations. She also has worked in Clinical Laboratories as a Medical Microbiology in her home country, Colombia.
Maria Paula holds an MS. in Health Care Management from Marymount University, VA, and a BS in Microbiology & Bioanalysis from the Industrial University of Santander, Colombia.
Shyreen Kamal, Pharm.D, Manager, Scientific Programs, Drug Information Association
Dr. Shyreen Kamal is the Manager of Scientific Programs for the Americas Region at DIA. She works closely with regulatory and industry stakeholders to manage, facilitate, and create content for DIA’s scientific programs including conferences, eLearning modules, short courses, and webinars. Dr. Kamal is a detail-oriented and analytical licensed pharmacist experienced in supporting clinical development and education through expert medical communication, scientific research, data management, and content creation. Dr. Kamal graduated from Shenandoah University with a Doctor of Pharmacy (Pharm.D) degree and is currently working on her Master's in Business Administration (MBA) with an entrepreneurship concentration.
Prior to DIA, she worked at the National Insititute of Health (NIH) where she managed clinical data for oncology and transplant clinical trials.